La cadena de opciones muestra datos clave de las opciones de acciones de Moolec Science a varios precios de ejercicio y fechas de vencimiento. Los operadores utilizan esta información para analizar posibles operaciones y evaluar el sentimiento del mercado para Moolec Science..

Moolec Science (NASDAQ:MLEC) Bolsa, Cadena de Opciones

Moolec Science

Moolec Science SA is a science-based ingredient company focused on producing real animal proteins in plants through Molecular Farming, a technology in the alternative protein landscape. Its purpose is to upgrade the taste, nutrition, and affordability of alternative protein products while building a more sustainable and equitable food system. The company has various products in its pipeline such as; TSP Valorasoy which is a soy protein product to produce vegetable proteins with texture and fibrousness similar to those of meat, Glaso, a safflower oil with high levels of gamma-linolenic acid, SPC2 which is a plant-based chymosin, YEEA1, an extract derived from a novel yeast biomass with specific properties, and others. The company's revenues arise from operations in Argentina.

Moolec Science SA

DA Davidson analyst Michael Shlisky maintains Miller Industries (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MLR#NYSE">MLR</a>) with a Buy and maintains $82 price target.

News

Price Target

Analyst Ratings

DA Davidson Maintains Buy on Miller Industries, Maintains $82 Price Target

RBC Capital analyst Luca Issi reiterates bluebird bio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLUE#NASDAQ">BLUE</a>) with a Sector Perform and maintains $4 price target.

Reiteration

BLUE

RBC Capital Reiterates Sector Perform on bluebird bio, Maintains $4 Price Target

Maxim Group analyst Jason McCarthy maintains Belite Bio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLTE#NASDAQ">BLTE</a>) with a Buy and raises the price target from $60 to $110.

BLTE

Maxim Group Maintains Buy on Belite Bio, Raises Price Target to $110

In the tech world, few <a href="https://www.benzinga.com/markets/24/10/41457050/bill-gates-once-said-he-was-so-jealous-of-apples-steve-jobs-and-labeled-him-a-genius-and-wizard-no-o">rivalries are as legendary</a> as that between Apple's Steve Jobs and <a href="https://www.benzinga.com/general/education/24/10/41580000/bill-gates-turns-69-5-things-you-might-not-know-about-microsoft-co-founder">Microsoft's Bill Gates</a>. The two pioneers changed the personal computer industry and how we use technology by pushing the envelope in their special ways for decades. However, when asked about his relationship with Gates in a rare joint interview, Jobs didn&#8217;t respond with competitiveness or rivalry – instead, he quoted a line from a Beatles song.
Don't Miss:
<ul>
<li>This Adobe-backed AI marketing startup went from a $5 to $85 million valuation working with brands like L'Oréal, Hasbro, and Sweetgreen in just three years –<a href="https://www.benzinga.com/money/rad-ai"> here's how there's a limited time opportunity to invest at $1,000 for only $0.50/share before closing date.</a></li>
<li>The global games market is projected to generate $272B by the end of the year —<a href="https://www.benzinga.com/money/gameflip"> for $0.55/share, this VC-backed startup with a 7M+ userbase gives investors easy access to this asset market.</a></li>
</ul>
During the 2007 <a href="https://www.youtube.com/watch?v=wvhW8cp15tk">interview</a>, Jobs and Gates reminisced about their long history in the industry. They laughed, remembering their early years when they were frequently the youngest in the room. Gates noted how it was always wonderful to see someone like Jobs persevere through the many challenges and trends offered by the rapidly changing computer sector.&nbsp;
Jobs, known for his passion for music, quoted The Beatles' reflective line: "You and I have memories longer than the road that stretches out ahead,&#8221; before adding, &#8220;And that&#8217;s clearly true here.&#8221;
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">When Steve Jobs was asked about his relationship with competitor and business rival, Bill Gates, he answered with a lyric from this reflective Beatles song: <a href="https://t.co/CovfClpMim">pic.twitter.com/CovfClpMim</a>
&mdash; The Beatles Earth (@BeatlesEarth) <a href="https://twitter.com/BeatlesEarth/status/1856357686956237143?ref_src=twsrc%5Etfw">November 12, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Trending: ‘Scrolling to UBI': Deloitte's #1 fastest-growing software company allows users to earn money on their phones –<a href="https://www.benzinga.com/money/mode-mobile-2"> invest today with $1,000 for just $0.25/share</a>
The lyric from The Beatles' "Two of Us" <a href="https://www.youtube.com/watch?v=cLQox8e9688">song</a> perfectly captured the sentiment. For all their competition, Jobs and Gates shared a deep mutual respect. The song is about friendship, shared memories and a sense of journey – and that's exactly how Jobs saw his connection with Gates. After all, they'd both been through the ups and downs of building billion-dollar companies, watching trends come and go and surviving the intense pressures of leading groundbreaking tech firms.
It was a moment that showed the softer side of their relationship and that despite being rivals, Jobs and Gates weren't just competing tech CEOs – they were two individuals who'd shared a unique journey in an industry they helped to shape. Their antagonism had subsided into camaraderie based on mutual knowledge of what it required to get to where they were, shared experiences and the <a href="https://www.benzinga.com/personal-finance/24/10/41340693/bill-gates-saved-rival-apple-from-bankruptcy-by-investing-150-million-steve-jobs-thanked-him-pub">rare act of cooperation</a>.
See Also: Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing —<a href="https://www.benzinga.com/money/boxabl"> you can become an investor for $0.80 per share today.</a>
Back in the late '70s and early '80s, Apple (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) was working hard to get its personal computers into homes, schools and offices, aiming to make computers friendly, accessible and even stylish. Microsoft (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>), on the other hand, was all about software under Gates&#8217; direction. Gates aimed to install Microsoft&#8217;s operating system on as many machines as possible, including IBM, Apple&#8217;s main rival. And a long-standing rivalry was sparked by this action.&nbsp;
Microsoft's Windows operating system, <a href="https://www.benzinga.com/tech/24/11/41872487/bill-gates-introduced-windows-41-years-ago-today-heres-how-much-youd-have-if-you-invested-1000-in-microsoft-when-it-went-public">introduced in 1983</a>, was strikingly similar to Apple's Mac OS and Jobs was not happy about it. He famously accused Gates of copying Apple&#8217;s interface, saying that Microsoft had no shame in borrowing ideas.
Ultimately, this brief Beatles reference from Jobs was a reminder of the humanity behind the industry giants. For those who grew up with either an Apple device or Microsoft software – most of us have used both – their partnership and rivalry have always felt like a part of our own experience with technology.
Read Next:
<ul>
<li>With over 7.8K investors including Meta, Google, And Amazon Execs — this AI Startup's valuation has skyrocketed from $5 million to $85 million in just three years. <a href="https://www.benzinga.com/money/rad-ai">Be an early investor with just $1,000 for only $0.50/share today before the offer closes in 2 weeks.</a></li>
<li>Deloitte's fastest-growing software company partners with Amazon, Walmart &amp; Target –<a href="https://www.benzinga.com/money/mode-mobile-2"> You can still get 4,000 of its pre-IPO shares for just $1,000</a></li>
</ul>

Startups

AAPL

MSFT

When Asked About His Business Rivalry With Bill Gates, Steve Jobs Replied With A Beatles Lyric From This Reflective Song

U.S. stocks traded lower midway through trading, with the S&amp;P 500 falling by over 1% on Friday.
The Dow traded down 0.90% to 43,356.00 while the NASDAQ fell 2.26% to 18,676.22. The S&amp;P 500 also fell, dropping, 1.42% to 5,864.40.
Check This Out: <a href="https://www.benzinga.com/24/11/42005109/top-4-utilities-stocks-that-may-keep-you-up-at-night-this-quarter">Top 4 Utilities Stocks That May Keep You Up At Night This Quarter</a>
Leading and Lagging Sectors Energy shares rose by 0.4% on Friday.
In trading on Friday, information technology shares fell by 1.9%.
Top Headline
U.S. retail sales rose 0.4% month-over-month in October compared to a revised 0.8% increase in September, and toping market estimates of 0.3%.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul>
<li>The Arena Group Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AREN#NYSE">AREN</a>) shares shot up 232% to $1.89 after it announced its first ever profitable quarter.</li>
<li>Shares of Bloom Energy Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BE#NYSE">BE</a>) got a boost, surging 49% to $19.80. Bloom Energy announced a 1 GW fuel cell deal with AEP, providing clean power for AI Data Centers.</li>
<li>Simpple Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SPPL#NASDAQ">SPPL</a>) shares were also up, gaining 90% to $1.6601 after the company announced a $400,000 contract to supply autonomous cleaning robots at Singapore&#8217;s International Airport Terminal.</li>
</ul>
Equities Trading DOWN
<ul>
<li>TFF Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TFFP#NASDAQ">TFFP</a>) shares dropped 78% to $0.3581 after the company announced it will wind down its operations.</li>
<li>Shares of Eyenovia, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EYEN#NASDAQ">EYEN</a>) were down 73% to $0.0932 after the company announced that its CHAPERONE trial is not meeting its primary endpoint, prompting the discontinuation of the study and a review of the full data set to evaluate next steps for the program.</li>
<li>Ryvyl Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RVYL#NASDAQ">RVYL</a>) was down, falling 33% to $1.1724 after the company reported worse-than-expected third-quarter financial results and cut its FY24 sales guidance.</li>
</ul>
Commodities In commodity news, oil traded down 0.5% to $68.35 while gold traded up 0.2% at $2,579.20.
Silver traded up 0.7% to $30.79 on Friday, while copper rose 0.8% to $4.1220.
Euro zone
European shares were mostly lower today. The eurozone's STOXX 600 fell 0.58%, Germany's DAX fell 0.16% and France's CAC 40 fell 0.26%. Spain's IBEX 35 Index gained 0.82%, while London's FTSE 100 fell 0.06%.
The annual inflation rate in Italy increased to 0.9% in October versus 0.7% in the prior month, while France&#8217;s annual inflation rate rose to 1.2% in October. The GDP in the UK grew by 1% year-over-year during the third quarter.
Asia Pacific Markets
Asian markets closed lower on Friday, with Japan's Nikkei 225 gaining 0.28%, Hong Kong's Hang Seng Index falling 0.05% and China's Shanghai Composite Index dipping 1.45%.
Hong Kong's economy expanded by 1.8% year-over-year in the third quarter compared to a 3.2% increase in the previous period. China&#8217;s retail sales rose by 4.8% year-over-year in October, while industrial production rose by 5.3% year-over-year in October.
Economics
<ul>
<li>The NY Empire State Manufacturing Index surged to 31.2 in November versus -11.9 in the previous month and topping market estimates of -0.7.</li>
<li>U.S. export prices increased by 0.8% in October, while import prices rose by 0.3% month-over-month in October.</li>
<li>U.S. retail sales rose 0.4% month-over-month in October compared to a revised 0.8% increase in September, and toping market estimates of 0.3%.</li>
<li>U.S. industrial production declined by 0.3% in October compared to a revised 0.5% declined in September.</li>
<li>U.S. business inventories rose 0.1% month-over-month in September compared to a 0.3% gain in August and versus market estimates of 0.2%.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/price-target/24/11/42007351/wall-streets-most-accurate-analysts-spotlight-on-3-consumer-stocks-with-over-7-dividend-yields">Wall Street&#8217;s Most Accurate Analysts Spotlight On 3 Consumer Stocks With Over 7% Dividend Yields</a></li>
</ul>

Earnings

Equities

Eurozone

Commodities

Intraday Update

Markets

Trading Ideas

AREN

EYEN

RVYL

SPPL

TFFP

S&P 500 Down Over 1%; US Retail Sales Top Expectations

Maxim Group analyst Allen Klee maintains Dolphin Entertainment (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DLPN#NASDAQ">DLPN</a>) with a Buy and lowers the price target from $8 to $5.

DLPN

Maxim Group Maintains Buy on Dolphin Entertainment, Lowers Price Target to $5

RBC Capital analyst Tom Narayan maintains Tesla (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) with a Outperform and raises the price target from $249 to $313.

TSLA

RBC Capital Maintains Outperform on Tesla, Raises Price Target to $313

DA Davidson analyst Linda Bolton Weiser maintains Sally Beauty Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SBH#NYSE">SBH</a>) with a Neutral and raises the price target from $12 to $13.

DA Davidson Maintains Neutral on Sally Beauty Holdings, Raises Price Target to $13

Maxim Group analyst Michael Diana maintains FlexShopper (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FPAY#NASDAQ">FPAY</a>) with a Buy and raises the price target from $2 to $4.

FPAY

Maxim Group Maintains Buy on FlexShopper, Raises Price Target to $4

DA Davidson analyst Michael Baker maintains Advance Auto Parts (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AAP#NYSE">AAP</a>) with a Neutral and maintains $45 price target.

DA Davidson Maintains Neutral on Advance Auto Parts, Maintains $45 Price Target

This article was originally published on <a href="https://cannabis.net/blog/news/no-spliff-for-you-rescheduling-cannabis-could-allow-for-hemp-tobacco-cigarettes-but-not-weed-an">Cannabis.net</a> and appears here with permission.
Marijuana rescheduling could permit CBD from hemp in tobacco, but not weed!
A recent report from the Congressional Research Service (CRS) has ignited discussions about the potential for incorporating hemp-<a href="https://cannabis.net/blog/medical/study-says-cbd-could-be-your-way-out-of-a-tobacco-addiction">derived cannabidiol (CBD) into tobacco products</a>, contingent upon the anticipated rescheduling of marijuana. As public perceptions of cannabis evolve and regulatory frameworks shift, this development could have profound implications for both the cannabis and tobacco industries, as well as for public health initiatives aimed at reducing smoking-related harm.
<h3>Understanding&nbsp;The Context Of Marijuana Rescheduling</h3>
Historically, marijuana has been classified as a Schedule I substance under the Controlled Substances Act (CSA), indicating that it is viewed as having no accepted medical use and a high potential for abuse. However, with growing evidence supporting the medicinal benefits of cannabis and changing public perceptions, there has been increasing momentum toward rescheduling marijuana. In August 2023, the Department of Health and Human Services (HHS) recommended that marijuana be reclassified to Schedule III, which would acknowledge its medical applications and significantly alter the regulatory landscape surrounding cannabis.
<h3>Implications Of Rescheduling</h3>
If marijuana is rescheduled to Schedule III, it would not only ease restrictions on research and development but also open new avenues for product innovation. According to the CRS report, while marijuana itself would still be prohibited in food, dietary supplements, or cosmetics,&nbsp;<a href="https://cannabis.net/blog/smoke/are-cbd-cigarettes-the-middle-ground-between-cannabis-and-tobacco">hemp-derived CBD could be used as an additive in tobacco</a>&nbsp;products without violating federal law. This distinction is crucial because it allows manufacturers to explore new formulations that combine the non-psychoactive properties of&nbsp;<a href="https://cannabis.net/blog/smoke/what-is-the-difference-between-a-spliff-a-joint-and-a-blunt-cannabis-101">CBD with traditional tobacco.</a>
<h3>The Rise Of CBD&nbsp;And Its Potential Benefits</h3>
CBD, or cannabidiol, is one of over 100 cannabinoids found in the cannabis plant. Unlike&nbsp;<a href="https://cannabis.net/blog/medical/what-is-thc-exactly-now-that-you-know-all-about-cbd">THC (tetrahydrocannabinol)</a>, which is responsible for the psychoactive effects commonly associated with marijuana, CBD does not produce a high. Instead, it has gained immense popularity due to its purported health benefits, including anxiety reduction, pain relief, anti-inflammatory properties, and potential neuroprotective effects.
As consumers become more health-conscious and seek alternatives to traditional pharmaceuticals, CBD has emerged as a viable option for many individuals looking to manage various health conditions. Its non-psychoactive nature makes it particularly appealing to those who wish to avoid the intoxicating effects of THC while still benefiting from the therapeutic properties of cannabis.
<h3>Potential Health Benefits Of CBD In Tobacco Products</h3>
<ul>
<li>Reduction in Cravings:&nbsp;By potentially inhibiting nicotine metabolism, CBD may help reduce cravings among smokers trying to quit or cut back on their tobacco use.</li>
</ul>
<ul>
<li>Anxiety Relief:&nbsp;Many smokers use cigarettes as a way to cope with stress or anxiety. Incorporating CBD into tobacco products could provide an alternative method for managing these feelings without resorting solely to nicotine.</li>
</ul>
<ul>
<li>Anti-inflammatory Properties: Research suggests that CBD may have anti-inflammatory effects that could counteract some of&nbsp;the harmful consequences of smoking.</li>
</ul>
<ul>
<li>Harm Reduction: The addition of CBD may make tobacco products less harmful by providing therapeutic benefits that could&nbsp;offset some negative health impacts associated with nicotine consumption.</li>
</ul>
Regulatory Considerations
Despite these promising developments, any products containing CBD would still require marketing authorization from the Food and Drug Administration (FDA) before they can be legally sold. The FDA&rsquo;s role in regulating hemp-derived products is crucial to ensuring consumer safety and product efficacy.
<h3>Public Health Implications</h3>
The potential introduction of CBD into tobacco products raises important public health considerations. While incorporating CBD may reduce some harmful effects associated with traditional smoking, it is crucial to assess whether this combination could inadvertently encourage smoking behavior among new users or young people.
Public health advocates will need to monitor these developments closely to ensure that any new products do not undermine efforts to reduce smoking rates or promote healthier alternatives. Additionally, ongoing research will be necessary to evaluate the long-term effects of using CBD in conjunction with nicotine.
<h3>Current Regulatory Landscape</h3>
As it stands, hemp-derived CBD is legal at the federal level due to the 2018 Farm Bill, which legalized hemp cultivation and removed hemp-derived products containing&nbsp;<a href="https://cannabis.net/blog/opinion/under-0.3-thc-by-net-weight-the-greatest-loophole-in-drug-law-history">less than 0.3% THC from Schedule I classification</a>. However, this legalization does not automatically grant approval for all hemp-derived products; they must still comply with FDA regulations regarding safety and labeling.
The FDA has expressed concerns ove&rdquo; unregulated CBD products flooding the market without proper testing or oversight. As such, manufacturers seeking to incorporate CBD into tobacco products will need to navigate a complex regulatory landscape while ensuring compliance with all applicable laws.
<h3>Potential Challenges Ahead</h3>
While the prospect of combining CBD with tobacco presents exciting opportunities, several challenges remain:
<ol>
<li>
Regulatory Hurdles: The FDA&rsquo;s approval process can be lengthy and complex. Manufacturers will need to demonstrate that their products meet safety standards and provide adequate labeling information.
</li>
<li>
Consumer Education: As CBD-infused tobacco products enter the market, educating consumers about their benefits and potential risks will be essential. Misunderstandings about CBD may lead to skepticism or misuse.
</li>
<li>
Market Competition: The tobacco industry is highly competitive; introducing new products requires significant investment in marketing and distribution channels.
</li>
<li>
Quality Control: Ensuring consistent quality across different batches of CBD-infused tobacco products will be critical for maintaining consumer trust and safety.
</li>
<li>
Public Health Concerns: While integrating CBD into tobacco may offer some benefits, there are concerns that it could inadvertently encourage smoking behavior among new users or young people who might view these products as safer alternatives.
</li>
</ol>
<h3>Conclusion</h3>
The report from the Congressional Research Service highlights a significant shift in how we might view the intersection between cannabis and tobacco industries if marijuana is rescheduled from Schedule I status under federal law. Such changes could pave pathways toward innovative product development incorporating hemp-derived ingredients like cannabidiol (CBD) within traditional smoking contexts&mdash;ultimately reshaping consumer choices while addressing pressing public health concerns related directly tied back towards smoking-related harms.
As stakeholders navigate this evolving landscape&mdash;collaboration between regulators researchers manufacturers&mdash;and public health officials will prove vital moving forward towards creating safe effective options available across diverse populations seeking healthier alternatives amidst ongoing challenges presented by both industries&rsquo; histories intertwined within broader societal contexts surrounding drug policy reform overall! By prioritizing safety efficacy through rigorous research transparent communication consumers, this new frontier product development holds promise leading healthier lifestyles across America&rsquo;s diverse population seeking better choices today.
This article is from an external unpaid contributor. It does not represent Benzinga&#39;s reporting and has not been edited for content or accuracy.

Cannabis

Government

Regulations

General

Rescheduling Cannabis Could Allow For Hemp Tobacco Cigarettes, But Not Weed And Tobacco Mixtures: No Spliff For You!

<a href="https://www.reuters.com/markets/commodities/china-cut-or-cancel-export-tax-rebates-products-including-aluminium-copper-2024-11-15/">https://www.reuters.com/markets/commodities/china-cut-or-cancel-export-tax-rebates-products-including-aluminium-copper-2024-11-15/</a>
&nbsp;
China's finance ministry said on Friday it would reduce or cancel export tax rebates for a wide range of commodities and other products, effective Dec. 1.
The country will reduce the export tax rebate rate for some refined oil products, photovoltaics, batteries, and certain non-metallic mineral products from 13% to 9%.
It will also cancel the rebate for aluminum and copper products and chemically modified animal, plant, or microbial oils and fats.
The announcement triggered a jump in aluminium prices on the London Metal Exchange as traders anticipated it may curb a heavy flow of Chinese aluminium abroad.
The news also contributed to a sharp rise in U.S. soyoil prices as it appeared Chinese used cooking oil would be covered by the changes.
Chinese shipments of used cooking oil to the <a href="https://www.reuters.com/markets/commodities/trump-trade-policy-seen-wild-card-us-soybean-farmers-opportunity-crushers-2024-11-13/">United States</a> and Europe for use in biofuel have challenged locally produced feedstocks like soyoil.
China's used cooking oil exports typically fall under the customs category of chemically modified animal, plant, or microbial oils and fats category, for which export rebates will be scrapped.

Macro Economic Events

Global

Economics

CENX

KALU

Reported Earlier, 'China To Cut Or Cancel Export Tax Rebates For Products Including Aluminum' - Reuters News

RBC Capital analyst Keith Mackey maintains Helmerich &amp; Payne (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HP#NYSE">HP</a>) with a Sector Perform and lowers the price target from $44 to $41.

RBC Capital Maintains Sector Perform on Helmerich & Payne, Lowers Price Target to $41

<a href="https://www.benzinga.com/markets/cryptocurrency/24/11/41819799/polymarket-ceo-on-election-night-it-looked-like-a-done-deal-on-platform-but-just-watching-">Polymarket predictions reveal</a> significant doubt over whether Matt Gaetz will be confirmed as Attorney General in a Trump administration, with current betting odds showing only a 28% chance of approval.
What Happened: The chances of confirmation have been oscillating between 25% and 30%, according to Polymarket <a href="https://polymarket.com/event/matt-gaetz-confirmed-as-attorney-general?tid=1731671553083">traders</a>.
The unconventional nomination has sparked widespread commentary, with former Speaker Kevin McCarthy (R-Calif.) casting <a href="https://www.benzinga.com/24/11/41997181/kevin-mccarthy-says-matt-gaetz-wont-get-confirmed-by-the-senate-and-everybody-knows-that">doubts on Gaetz's chances. </a>
McCarthy, a long-time Trump ally, remarked in an interview with Bloomberg that "Gaetz won't get confirmed. Everybody knows that," suggesting that Gaetz lacks strong support among Senate Republicans due to his divisive history within the party. 
McCarthy's own relationship with Gaetz has been tumultuous, particularly after Gaetz led the charge to oust him as speaker of the House 
Gaetz, known for his libertarian views and advocacy for cryptocurrency, has introduced radical proposals, including a bill to allow federal <a href="https://www.benzinga.com/news/legal/24/11/41956594/matt-gaetz-is-trumps-attorney-general-pick-would-be-top-cop-is-under-house-ethics-investigation">income taxes to be paid in Bitcoin</a>.
His potential nomination as Attorney General is part of Trump's promise to overhaul the Justice Department and address what he calls the <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/41964758/trumps-attorney-general-pick-matt-gaetz-once-proposed-collecting-federal-income-taxes-in-bitcoin-apart-from-co-sponsoring-bill-to-abolish-the-fed">"weaponization" of government institutions</a>.
Trump publicly praised Gaetz on his Truth Social account, stating, "Matt will end Weaponized Government, Protect our Borders, dismantle Criminal Organizations, and restore Americans' badly-shattered Faith and Confidence in the Justice Department."
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/events/digital-assets/ "><img loading="lazy" decoding="async" width="300" height="250" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/03/29155259/905735A6-57D3-4874-9AA1-75D037842DB3-2.gif" alt="Benzinga Future of Digital Assets conference" class="wp-image-270548" /></a></figure>
Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42011875/solana-ripple-litecoin-etfs-may-be-on-the-table-under-trump-administration-industry-experts-think">Solana, Ripple, Litecoin ETFs May Be On The Table Under Trump Administration, Industry Experts Say</a>
Gaetz's path to confirmation is complicated by ongoing controversies. The House Ethics Committee is investigating him for allegations of sexual misconduct, drug use, and other claims, though Gaetz has consistently denied any wrongdoing.
The Department of Justice previously investigated him for sex trafficking but decided against pressing charges last year. 
For many Senate Republicans, these unresolved issues could prove insurmountable during the confirmation process .
Adding to his profile, Gaetz has also pushed for legislation to dismantle the Federal Reserve and legalize marijuana. 
His pro-crypto stance aligns with Trump's campaign promise to make the U.S. the "Bitcoin superpower of the world," a stance that has fueled excitement within the crypto community. 
What&#8217;s Next: Gaetz's involvement in crypto and his support for innovative financial policies make his nomination particularly relevant as investors await Benzinga&#8217;s <a href="https://www.benzinga.com/events/digital-assets/agenda/">Future of Digital Assets</a> event on Nov. 19.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42011697/bitcoin-hacker-sentenced-to-5-years-for-laundering-billions-in-crypto-theft">Bitcoin Hacker Sentenced To 5 Years For Laundering Billions In Crypto Theft</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Matt Gaetz To Be Confirmed As Attorney General In A Trump Administration? Not So Fast, Polymarket Traders Say

WIIM

Alcoa shares are trading higher amid strength in aluminum after China reportedly indicated it would reduce export tax rebates on a range of commodities.

Maxim Group analyst Allen Klee maintains Roadzen (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RDZN#NASDAQ">RDZN</a>) with a Buy and lowers the price target from $7 to $4.

RDZN

Maxim Group Maintains Buy on Roadzen, Lowers Price Target to $4

Live On CNBC, Jenny Harrington Announces Trimmed American Express Company

This whale alert can help traders discover the next big trading opportunities.
Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.
Traders often look for circumstances when the market estimation of an option diverges away from its normal worth. Abnormal amounts of trading activity could push option prices to hyperbolic or underperforming levels. 
Below are some instances of options activity happening in the Financials sector: 
<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>COIN</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>11/22/24</td>
<td>$320.00</td>
<td>$127.0K</td>
<td>1.3K</td>
<td>4.1K</td>
</tr>
<tr>
<td>RITM</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>11/15/24</td>
<td>$10.00</td>
<td>$75.2K</td>
<td>4.5K</td>
<td>1.5K</td>
</tr>
<tr>
<td>STNE</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/15/27</td>
<td>$5.00</td>
<td>$285.4K</td>
<td>26</td>
<td>1.5K</td>
</tr>
<tr>
<td>BAC</td>
<td>PUT</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>03/21/25</td>
<td>$43.00</td>
<td>$120.0K</td>
<td>1.1K</td>
<td>1.0K</td>
</tr>
<tr>
<td>C</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$65.00</td>
<td>$63.1K</td>
<td>48.3K</td>
<td>722</td>
</tr>
<tr>
<td>PYPL</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>11/22/24</td>
<td>$86.00</td>
<td>$42.0K</td>
<td>3.4K</td>
<td>602</td>
</tr>
<tr>
<td>PGR</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$255.00</td>
<td>$77.5K</td>
<td>14</td>
<td>260</td>
</tr>
<tr>
<td>WFC</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/15/27</td>
<td>$100.00</td>
<td>$25.0K</td>
<td>501</td>
<td>200</td>
</tr>
<tr>
<td>PRU</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$125.00</td>
<td>$134.6K</td>
<td>330</td>
<td>163</td>
</tr>
<tr>
<td>HOOD</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$45.00</td>
<td>$25.9K</td>
<td>189</td>
<td>130</td>
</tr>
</tbody>
</table>

<h2>Explanation</h2>
These itemized elaborations have been created using the accompanying table. 
• For COIN (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COIN#NASDAQ">COIN</a>), we notice a call option trade that happens to be bullish, expiring in 7 day(s) on November 22, 2024. This event was a transfer of 200 contract(s) at a $320.00 strike. The total cost received by the writing party (or parties) was $127.0K, with a price of $635.0 per contract. There were 1321 open contracts at this strike prior to today, and today 4120 contract(s) were bought and sold. 
• For RITM (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RITM#NYSE">RITM</a>), we notice a call option sweep that happens to be bearish, is expiring today. Parties traded 1003 contract(s) at a $10.00 strike. This particular call needed to be split into 25 different trades to become filled. The total cost received by the writing party (or parties) was $75.2K, with a price of $75.0 per contract. There were 4589 open contracts at this strike prior to today, and today 1515 contract(s) were bought and sold. 
• Regarding STNE (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STNE#NASDAQ">STNE</a>), we observe a call option trade with bullish sentiment. It expires in 791 day(s) on January 15, 2027. Parties traded 499 contract(s) at a $5.00 strike. The total cost received by the writing party (or parties) was $285.4K, with a price of $572.0 per contract. There were 26 open contracts at this strike prior to today, and today 1513 contract(s) were bought and sold. 
• For BAC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BAC#NYSE">BAC</a>), we notice a put option trade that happens to be neutral, expiring in 126 day(s) on March 21, 2025. This event was a transfer of 1000 contract(s) at a $43.00 strike. The total cost received by the writing party (or parties) was $120.0K, with a price of $120.0 per contract. There were 1124 open contracts at this strike prior to today, and today 1003 contract(s) were bought and sold. 
• For C (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/C#NYSE">C</a>), we notice a call option trade that happens to be bullish, expiring in 63 day(s) on January 17, 2025. This event was a transfer of 112 contract(s) at a $65.00 strike. The total cost received by the writing party (or parties) was $63.1K, with a price of $564.0 per contract. There were 48320 open contracts at this strike prior to today, and today 722 contract(s) were bought and sold. 
• Regarding PYPL (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PYPL#NASDAQ">PYPL</a>), we observe a put option sweep with bullish sentiment. It expires in 7 day(s) on November 22, 2024. Parties traded 300 contract(s) at a $86.00 strike. This particular put needed to be split into 3 different trades to become filled. The total cost received by the writing party (or parties) was $42.0K, with a price of $140.0 per contract. There were 3456 open contracts at this strike prior to today, and today 602 contract(s) were bought and sold. 
• Regarding PGR (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PGR#NYSE">PGR</a>), we observe a put option sweep with bearish sentiment. It expires in 63 day(s) on January 17, 2025. Parties traded 76 contract(s) at a $255.00 strike. This particular put needed to be split into 3 different trades to become filled. The total cost received by the writing party (or parties) was $77.5K, with a price of $1020.0 per contract. There were 14 open contracts at this strike prior to today, and today 260 contract(s) were bought and sold. 
• For WFC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WFC#NYSE">WFC</a>), we notice a call option trade that happens to be bearish, expiring in 791 day(s) on January 15, 2027. This event was a transfer of 50 contract(s) at a $100.00 strike. The total cost received by the writing party (or parties) was $25.0K, with a price of $500.0 per contract. There were 501 open contracts at this strike prior to today, and today 200 contract(s) were bought and sold. 
• For PRU (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PRU#NYSE">PRU</a>), we notice a put option sweep that happens to be bearish, expiring in 217 day(s) on June 20, 2025. This event was a transfer of 162 contract(s) at a $125.00 strike. This particular put needed to be split into 3 different trades to become filled. The total cost received by the writing party (or parties) was $134.6K, with a price of $834.0 per contract. There were 330 open contracts at this strike prior to today, and today 163 contract(s) were bought and sold. 
• Regarding HOOD (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOOD#NASDAQ">HOOD</a>), we observe a call option trade with bearish sentiment. It expires in 217 day(s) on June 20, 2025. Parties traded 100 contract(s) at a $45.00 strike. The total cost received by the writing party (or parties) was $25.9K, with a price of $259.0 per contract. There were 189 open contracts at this strike prior to today, and today 130 contract(s) were bought and sold. 
Options Alert Terminology 
 - Call Contracts: The right to buy shares as indicated in the contract. 
 - Put Contracts: The right to sell shares as indicated in the contract. 
 - Expiration Date: When the contract expires. One must act on the contract by this date if one wants to use it. 
 - Premium/Option Price: The price of the contract. 
For more information, visit our <a href="https://pro.benzinga.com/blog/how-to-understand-option-alerts/">Guide to Understanding Options Alerts</a> or read <a href="https://www.benzinga.com/markets/options">more news on unusual options activity</a>. 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Options

COIN

HOOD

PYPL

RITM

STNE

10 Financials Stocks Whale Activity In Today's Session

Amazon.com Inc's (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) much-anticipated live-action Tomb Raider TV series appears close to <a href="https://www.benzinga.com/general/entertainment">landing its lead. </a>
<a href="https://deadline.com/2024/11/sophie-turner-lara-croft-tomb-raider-phoebe-waller-bridge-amazon-1236173978/">According</a> to Deadline, Sophie Turner — best known for her role as Sansa Stark in &#8220;Game of Thrones&#8221; — is reportedly in negotiations to take on <a href="https://www.benzinga.com/general/entertainment/24/04/38096633/this-is-the-most-iconic-character-in-gaming-surpassing-mario-hitman-sonic-says-bafta-gaming">the iconic role of Lara Croft</a>, the adventurous archaeologist who has been a staple of pop culture since the original Tomb Raider game launched in 1996.
This live-action series, separate from Netflix Inc's (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NFLX#NASDAQ">NFLX</a>) animated adaptation, was first announced in January 2023. It boasts <a href="https://www.benzinga.com/general/entertainment/24/05/38854134/amazon-confirms-live-action-tomb-raider-series-by-fleabags-phoebe-waller-bridge-i-think-my-">Phoebe Waller-Bridge (Fleabag, Killing Eve) as its writer</a>, with Amazon officially confirming her involvement in May. Beyond that, details have been scarce.
See Also: <a href="https://www.benzinga.com/general/entertainment/24/11/41952433/hbo-reveals-release-window-for-the-last-of-us-season-2">HBO Reveals Release Window For The Last Of Us Season 2</a>
<h3 class="wp-block-heading">A Fresh Take On Lara Croft</h3>
Casting Lara Croft comes with high expectations. Angelina Jolie first brought the character to life on the big screen in the early 2000s, delivering a larger-than-life portrayal that set the tone for future adaptations. Alicia Vikander later brought a grittier and more grounded interpretation of Lara in the 2018 reboot.
With Turner reportedly in the final stages of negotiations, fans are eager to see what she can bring to the role. Known for her layered portrayal of Sansa Stark, Turner has proven her ability to balance vulnerability and strength—qualities central to <a href="https://www.benzinga.com/general/entertainment/24/04/38096633/this-is-the-most-iconic-character-in-gaming-surpassing-mario-hitman-sonic-says-bafta-gaming">the character of Lara Croft.</a>
Earlier reports suggested Turner was competing with Lucy Boynton (Bohemian Rhapsody) for the role, but this latest update points to Turner emerging as Amazon's choice.
<h3 class="wp-block-heading">Expanding The Tomb Raider Universe</h3>
Amazon has ambitious plans for the Tomb Raider franchise. Alongside the TV series, the company will also publish the next Tomb Raider video game developed by Square Enix Holdings Co. (OTC:<a class="ticker" href="https://www.benzinga.com/stock/SQNXF#OTC">SQNXF</a>) Crystal Dynamics. Additionally, a new film adaptation is reportedly in the works, signaling a coordinated effort to revitalize the franchise across multiple media platforms.
For fans of classic Tomb Raider games, there's even more to celebrate. Embracer Group&#8216;s (OTC:<a class="ticker" href="https://www.benzinga.com/stock/THQQF#OTC">THQQF</a>) Aspyr Media recently announced a remastered collection of Tomb Raider IV-VI, set to release in 2024. 
Read Next:
<ul>
<li><a href="https://www.benzinga.com/general/gaming/24/11/41996022/embracers-earnings-struggle-as-game-delays-restructuring-weigh-on-results">Embracer&#8217;s Earnings Struggle As Game Delays, Restructuring Weigh On Results</a></li>
</ul>
Image created using photos from Shutterstock.

Entertainment

Gaming

AMZN

NFLX

SQNXF

THQQF

Sophie Turner Set To Star As Lara Croft In Amazon's Tomb Raider TV Series: Report

This whale alert can help traders discover the next big trading opportunities.
Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.
Traders will search for circumstances when the market estimation of an option diverges heavily from its normal worth. High amounts of trading activity could push option prices to exaggerated or underestimated levels. 
Below are some instances of options activity happening in the Consumer Discretionary sector: 
<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>TSLA</td>
<td>PUT</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>11/15/24</td>
<td>$320.00</td>
<td>$33.5K</td>
<td>16.5K</td>
<td>60.1K</td>
</tr>
<tr>
<td>AMZN</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>12/20/24</td>
<td>$210.00</td>
<td>$25.1K</td>
<td>11.6K</td>
<td>3.3K</td>
</tr>
<tr>
<td>CVNA</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>12/06/24</td>
<td>$255.00</td>
<td>$88.0K</td>
<td>77</td>
<td>3.3K</td>
</tr>
<tr>
<td>LVS</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>11/15/24</td>
<td>$48.50</td>
<td>$29.0K</td>
<td>1.0K</td>
<td>1.0K</td>
</tr>
<tr>
<td>BIRK</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>12/20/24</td>
<td>$45.00</td>
<td>$240.0K</td>
<td>4.5K</td>
<td>1.0K</td>
</tr>
<tr>
<td>PDD</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>11/29/24</td>
<td>$130.00</td>
<td>$40.8K</td>
<td>1.2K</td>
<td>946</td>
</tr>
<tr>
<td>ABNB</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>12/20/24</td>
<td>$135.00</td>
<td>$45.7K</td>
<td>1.8K</td>
<td>287</td>
</tr>
<tr>
<td>CAVA</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$140.00</td>
<td>$30.0K</td>
<td>1.0K</td>
<td>182</td>
</tr>
<tr>
<td>GM</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>03/21/25</td>
<td>$52.50</td>
<td>$28.2K</td>
<td>2.9K</td>
<td>154</td>
</tr>
<tr>
<td>DPZ</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>12/06/24</td>
<td>$460.00</td>
<td>$48.0K</td>
<td>46</td>
<td>126</td>
</tr>
</tbody>
</table>

<h2>Explanation</h2>
These itemized elaborations have been created using the accompanying table. 
• For TSLA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>), we notice a put option trade that happens to be neutral, is expiring today. Parties traded 100 contract(s) at a $320.00 strike. The total cost received by the writing party (or parties) was $33.5K, with a price of $335.0 per contract. There were 16570 open contracts at this strike prior to today, and today 60112 contract(s) were bought and sold. 
• Regarding AMZN (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>), we observe a put option trade with bullish sentiment. It expires in 35 day(s) on December 20, 2024. Parties traded 25 contract(s) at a $210.00 strike. The total cost received by the writing party (or parties) was $25.1K, with a price of $1007.0 per contract. There were 11655 open contracts at this strike prior to today, and today 3337 contract(s) were bought and sold. 
• For CVNA (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVNA#NYSE">CVNA</a>), we notice a call option trade that happens to be bullish, expiring in 21 day(s) on December 6, 2024. This event was a transfer of 200 contract(s) at a $255.00 strike. The total cost received by the writing party (or parties) was $88.0K, with a price of $440.0 per contract. There were 77 open contracts at this strike prior to today, and today 3301 contract(s) were bought and sold. 
• For LVS (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LVS#NYSE">LVS</a>), we notice a put option trade that happens to be bullish, is expiring today. Parties traded 1000 contract(s) at a $48.50 strike. The total cost received by the writing party (or parties) was $29.0K, with a price of $29.0 per contract. There were 1083 open contracts at this strike prior to today, and today 1007 contract(s) were bought and sold. 
• For BIRK (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BIRK#NYSE">BIRK</a>), we notice a put option trade that happens to be bullish, expiring in 35 day(s) on December 20, 2024. This event was a transfer of 1000 contract(s) at a $45.00 strike. The total cost received by the writing party (or parties) was $240.0K, with a price of $240.0 per contract. There were 4512 open contracts at this strike prior to today, and today 1000 contract(s) were bought and sold. 
• For PDD (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PDD#NASDAQ">PDD</a>), we notice a call option trade that happens to be bearish, expiring in 14 day(s) on November 29, 2024. This event was a transfer of 300 contract(s) at a $130.00 strike. The total cost received by the writing party (or parties) was $40.8K, with a price of $136.0 per contract. There were 1283 open contracts at this strike prior to today, and today 946 contract(s) were bought and sold. 
• For ABNB (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ABNB#NASDAQ">ABNB</a>), we notice a call option sweep that happens to be bullish, expiring in 35 day(s) on December 20, 2024. This event was a transfer of 127 contract(s) at a $135.00 strike. This particular call needed to be split into 4 different trades to become filled. The total cost received by the writing party (or parties) was $45.7K, with a price of $360.0 per contract. There were 1891 open contracts at this strike prior to today, and today 287 contract(s) were bought and sold. 
• Regarding CAVA (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CAVA#NYSE">CAVA</a>), we observe a call option trade with bullish sentiment. It expires in 63 day(s) on January 17, 2025. Parties traded 25 contract(s) at a $140.00 strike. The total cost received by the writing party (or parties) was $30.0K, with a price of $1200.0 per contract. There were 1096 open contracts at this strike prior to today, and today 182 contract(s) were bought and sold. 
• Regarding GM (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GM#NYSE">GM</a>), we observe a put option trade with bullish sentiment. It expires in 126 day(s) on March 21, 2025. Parties traded 123 contract(s) at a $52.50 strike. The total cost received by the writing party (or parties) was $28.2K, with a price of $230.0 per contract. There were 2943 open contracts at this strike prior to today, and today 154 contract(s) were bought and sold. 
• For DPZ (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DPZ#NYSE">DPZ</a>), we notice a call option trade that happens to be bullish, expiring in 21 day(s) on December 6, 2024. This event was a transfer of 100 contract(s) at a $460.00 strike. The total cost received by the writing party (or parties) was $48.0K, with a price of $480.0 per contract. There were 46 open contracts at this strike prior to today, and today 126 contract(s) were bought and sold. 
Options Alert Terminology 
 - Call Contracts: The right to buy shares as indicated in the contract. 
 - Put Contracts: The right to sell shares as indicated in the contract. 
 - Expiration Date: When the contract expires. One must act on the contract by this date if one wants to use it. 
 - Premium/Option Price: The price of the contract. 
For more information, visit our <a href="https://pro.benzinga.com/blog/how-to-understand-option-alerts/">Guide to Understanding Options Alerts</a> or read <a href="https://www.benzinga.com/markets/options">more about unusual options activity</a>. 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ABNB

BIRK

CAVA

CVNA

Citigourp Global Markets 2% Protected Notes Linked To The Djia

10 Consumer Discretionary Stocks With Whale Alerts In Today's Session

Moolec Science (MLEC) has released an update. Moolec Science SA has inked a three-year offtake agreement with a leading global CPG company to suppl...

Moolec Science Gears Up for 2025 Market Entry

Maxim Group analyst Anthony Vendetti reiterated a Buy rating on Moolec Science (MLEC – Research Report) yesterday and set a price target of $6.00. ...

Buy Rating Affirmed: Moolec Science Poised for Growth with Strategic Partnerships and Strong Market Potential

Moolec Science (MLEC) has released an update. Moolec Science and Bunge have forged a partnership to develop new safflower varieties, enhancing prod...

Moolec Science and Bunge's Strategic Safflower Venture

Warning: MLEC is at high risk of performing badly

Moolec Science (MLEC) has released an update. Moolec Science SA, a leader in molecular farming for food ingredients, has been notified by Nasdaq of...

Moolec Science Faces Nasdaq Compliance Challenge

Moolec Science gets non-compliance notice from Nasdaq

Earnings week ahead: Nike, Carnival, Constellation Brands, and more

Moolec Science GAAP EPS of -$0.07, revenue of $1.52M

Moolec Science (MLEC) Q4 2024 Earnings Call Transcript

Moolec Science (MLEC) has released an update. Moolec Science has achieved a groundbreaking milestone by securing USDA approval for its genetically ...

Moolec Science Gains Historic USDA Approval

AIXI

ANGO

APOG

CALM

LEVI

LFCR

MESA

MLEC

MLECW

NEOV

PAYX

POCI

STBX

TRAK

UNFI

VLGEA

WKEY

Biotech

Press Releases

Moolec Science to Host First Quarter Fiscal Year 2024 Business Update Conference Call

Opinion

Thinking about buying stock in Moolec Science, Bakkt Holdings, EHang Holdings, Arcadium Lithium, or Assertio Holdings?

Moolec Science to Host Second Quarter Fiscal Year 2024 Business Update Conference Call

Moolec Science to Host Third Quarter Fiscal Year 2024 Business Update Conference Call

Moolec Signs an Offtake Agreement With Major Global CPG Company to Hit the US Market in 2025

Moolec Received NASDAQ Bid Price Letter

Moolec Science to Host Fourth Quarter Fiscal Year 2024 Business Update Conference Call

Moolec Science Presents Fiscal Year 2024 Annual Business Update

Legal

Moolec Has Received USDA Approval for the First Genetically Modified Pea in History

ASRT

BKKT

LTHM

Forafric Global

Branchout Food

Barfresh Food Group

Bridgford Foods Corporation - Common Stock

Bridgford Foods

Borealis Foods Inc. - Class A Common Shares

Borealis Foods

Better Choice Co

Beyond Meat

Australian Oilseeds Holdings Limited - Ordinary Shares

Australian Oilseeds Hldgs

DDC Enterprise Limited Class A Ordinary Shares

DDC Enterprise

Farmer Bros

CIMG

Coffee Holding Co

Laird Superfood

Lifeway Foods

Mama`s Creations

Oriental Rise Holdings Limited - Ordinary Shares

Oriental Rise Holdings

TDH Hldgs

Planet Green Holdings

The Real Good Food Company, Inc. - Class A Common Stock

Real Good Food Co

Rocky Mountain Chocolate Factory, Inc. - Common Stock

Rocky Mountain Chocolate

Stryve Foods, Inc. - Class A Common Stock

Stryve Foods

Sow Good

Steakholder Foods Ltd. - American Depositary Shares

Steakholder Foods

Top Wealth Group Holding Limited - Ordinary Shares

Comments

Moolec Science

Moolec Science (MLEC) Opciones

No option chain data available. Please try again later

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL